Fort Lauderdale, FL1 Active Studies

Parkinsons Disease Clinical Trials in Fort Lauderdale, FL

Find 1 actively recruiting parkinsons disease clinical trials in Fort Lauderdale, FL. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
40
Enrolling

Recruiting Parkinsons Disease Studies in Fort Lauderdale

About Parkinsons Disease Clinical Trials in Fort Lauderdale

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 1 parkinsons disease clinical trials recruiting participants in Fort Lauderdale, FL. These studies are seeking a combined 40 participants. Research is being sponsored by Nova Southeastern University. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in Fort Lauderdale — FAQ

Are there parkinsons disease clinical trials in Fort Lauderdale?

Yes, there are 1 parkinsons disease clinical trials currently recruiting in Fort Lauderdale, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fort Lauderdale?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fort Lauderdale research site will contact you about next steps.

Are clinical trials in Fort Lauderdale free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fort Lauderdale studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 1 active trials in Fort Lauderdale are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated July 21, 2026 from ClinicalTrials.gov